Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety Evaluation of MODI, an Insulin Titration Algorithm, in Adults With Diabetes

NCT07599982 is registered in ClinicalTrials.gov with DreaMed Diabetes as lead sponsor.

NCT NCT07599982
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07599982 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety Evaluation of MODI, an Insulin Titration Algorithm, in Adults With Diabetes
Lead sponsor
DreaMed Diabetes
Phase
Not applicable
Overall status
Recruiting
Start date
May 25, 2026
Completion date
January 31, 2027
Enrollment
102 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

type 1 diabetes (t1d), type 2 diabetes (t2d)